Abstract
This article contains first person accounts in narrative and visual form created by clients and family members who have participated in the Early Detection and Intervention for the Prevention of Psychosis Program (EDIPPP). By the time most individuals join EDIPPP they have been experiencing a confusing constellation of thought and behavior changes. For most, EDIPPP signifies the next step in a journey of trying to reclaim a sense of agency in their lives and promise for the future. Understanding the process youth and families go through to make meaning of a “high risk” indication is critical for the clinicians who work with these families. By highlighting these first person accounts and the story they tell, we strive to contribute to this understanding and thereby enrich our discussion of the early detection and intervention for psychosis with the perspectives of individuals participating in our study. These narratives point to the potential value of further research focused specifically on how youth and families come to understand being at risk for psychosis.
Keywords: Adolescents, first person accounts, psychosis, schizophrenia, prodromal psychosis, high risk, recovery
Adolescent Psychiatry
Title:In the First Person: A Window into the Experience of Early Psychosis and Recovery
Volume: 2 Issue: 2
Author(s): Margaret Migliorati, Melina Salvador, Elizabeth Spring-Nichols, Sarah Lynch Tamara Sale and Steven Adelsheim
Affiliation:
Keywords: Adolescents, first person accounts, psychosis, schizophrenia, prodromal psychosis, high risk, recovery
Abstract: This article contains first person accounts in narrative and visual form created by clients and family members who have participated in the Early Detection and Intervention for the Prevention of Psychosis Program (EDIPPP). By the time most individuals join EDIPPP they have been experiencing a confusing constellation of thought and behavior changes. For most, EDIPPP signifies the next step in a journey of trying to reclaim a sense of agency in their lives and promise for the future. Understanding the process youth and families go through to make meaning of a “high risk” indication is critical for the clinicians who work with these families. By highlighting these first person accounts and the story they tell, we strive to contribute to this understanding and thereby enrich our discussion of the early detection and intervention for psychosis with the perspectives of individuals participating in our study. These narratives point to the potential value of further research focused specifically on how youth and families come to understand being at risk for psychosis.
Export Options
About this article
Cite this article as:
Migliorati Margaret, Salvador Melina, Spring-Nichols Elizabeth, Tamara Sale Sarah Lynch and Adelsheim Steven, In the First Person: A Window into the Experience of Early Psychosis and Recovery , Adolescent Psychiatry 2012; 2(2) . https://dx.doi.org/10.2174/2210676611202020146
DOI https://dx.doi.org/10.2174/2210676611202020146 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
New Insights into the Biology of 1-Antitrypsin and its Role in Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Steroid Hybrid Systems: New Molecular Entities with Potential Therapeutical Spectrum
Current Drug Therapy ACE Inhibition, p300, Serum Nitrite and Lipid Peroxidation in Newly Diagnosed Hypertensives
Vascular Disease Prevention (Discontinued) Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based Drugs
Current Medicinal Chemistry Ginkgo Biloba Extract (EGb 761) and CNS Functions Basic Studies and Clinical Applications
Current Drug Targets Naturally Inspired Pyrimidines Analogues for Alzheimer’s Disease
Current Neuropharmacology Borderline Personality Disorder in Young People and the Prospects for Prevention and Early Intervention
Current Psychiatry Reviews An Overview of Galenic Preparation Methods for Medicinal Cannabis
Current Bioactive Compounds Chemoprevention with Phytonutrients and Microalgae Products in Chronic Inflammation and Colon Cancer
Current Pharmaceutical Design Epigenetic Targets and their Inhibitors in Cancer Therapy
Current Topics in Medicinal Chemistry Imaging Reporters and Multimodal Molecular Bio-Imaging: A Database of Available Probes for Multi-Modality Bio-Imaging of Reporter Gene Expression
Recent Patents on Medical Imaging Application of Mitochondria-Targeted Pharmaceuticals for the Treatment of Heart Disease
Current Pharmaceutical Design Carbon Monoxide - Toxicity of Low-Dose Application
Current Pharmaceutical Biotechnology HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview
Current Drug Metabolism Mephedrone Impact on Matrix Metalloproteinases Activity - Do they Influence the Memory Processes?
Current Molecular Pharmacology Effectiveness of a School-Based Emotional Freedom Techniques Intervention for Promoting Student Wellbeing
Adolescent Psychiatry Molecular, Cellular and Clinical Aspects of Intracerebral Hemorrhage: Are the Enemies Within?
Current Neuropharmacology Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease
Current Topics in Medicinal Chemistry The Application of Metabolomic Profiling to the Effects of Physical Activity
Current Metabolomics The Prophylactic Use of Antiepileptic Drugs in Patients Scheduled for Neurosurgery
Current Pharmaceutical Design